Daily BriefsMost Read

Most Read: HDFC Bank, Socionext, Alibaba Group Holding , Plus Alpha Consulting, Eoptolink Technology Inc Ltd, JSR Corp, Kelun Biotech, Liontown Resources and more

In today’s briefing:

  • Socionext Placement – Valuation More Reasonable but past Secondary Offerings Have a Mixed Record
  • Index Rebalance & ETF Flow Recap: HSCI, HSCEI, HSI, CSI300, CSI500, SSE50, HDFC Bank, Sensex
  • Socionext (6526 JP): The Current Playbook
  • Ant Group’s $6.0bn Buyback Move Casts Doubt on IPO Prospects
  • Plus Alpha Consulting Placement – Pulling Out All Stops for Deal Success as Insiders Are Selling
  • ChiNext/​​​ChiNext50 Index Rebalance Preview: Potential Changes & Basket Performance
  • TOPIX Inclusions: Who Is Ready (Jul 2023)
  • JSR (4185 JP) Takeover – Why So Wide? FUD and Flows
  • Kelun-Biotech (科伦博泰) IPO Trading: Lukewarm Demand but Peers Have Done Well Recently
  • S&P/​​​​​​​​ASX Index Rebalance Preview: Potential Changes in September


Socionext Placement – Valuation More Reasonable but past Secondary Offerings Have a Mixed Record

By Sumeet Singh


Index Rebalance & ETF Flow Recap: HSCI, HSCEI, HSI, CSI300, CSI500, SSE50, HDFC Bank, Sensex

By Brian Freitas


Socionext (6526 JP): The Current Playbook

By Arun George

  • Since the announcement of the US$1.9 billion secondary placement, Socionext (6526 JP)’s shares are down -25.0% from the undisturbed price of JPY21,950 per share (5 July).
  • So far, Socionext’s shares have mostly followed the pattern of previous large placements. Investors participating in previous large Japanese placements tend to secure positive returns.
  • The offering will likely be priced on 11 July. Due to the steep share price decline, Socionext is trading at an undemanding multiple compared to global SoC peers.  

Ant Group’s $6.0bn Buyback Move Casts Doubt on IPO Prospects

By Oshadhi Kumarasiri

  • China’s regulators on Friday imposed Ant Financial Services Group (6688 HK) with a fine of RMB 7.12bn. A day later, Ant Group unveiled a share buyback program worth $6bn.
  • The last time media created a positive narrative around Ant Group was in January 2023 when Jack Ma relinquished control of the company.
  • However, the media excitement was short-lived as Alibaba Group Holding (9988 HK)‘s share price quickly resumed a downward trend after rising by around 22%.

Plus Alpha Consulting Placement – Pulling Out All Stops for Deal Success as Insiders Are Selling

By Sumeet Singh

  • Three shareholders of Plus Alpha Consulting (4071 JP) (PAC) aim to raise around US$230m via selling over 26% of the company.
  • PAC was listed in 2021 and after a somewhat tepid initial performance it has been doing well over the past year.
  • In this note, we talk about the deal dynamics and run the deal through our ECM framework

ChiNext/​​​ChiNext50 Index Rebalance Preview: Potential Changes & Basket Performance

By Brian Freitas

  • One third of the way through the review period, we forecast 10 changes for the ChiNext Index (SZ399006 INDEX EQUITY) and 5 changes for the ChiNext 50 Index in December.
  • Passive trackers are estimated to trade around +/-0.5 days ADV on most of the potential adds/deletes, though there are some deletes that will have over 1 day ADV to sell.
  • The potential inclusion to one or both indices have outperformed the potential deletes by a huge margin in the 5 months. We’d wait for a pullback to re-enter positions.

TOPIX Inclusions: Who Is Ready (Jul 2023)

By Janaghan Jeyakumar, CFA

  • Quiddity’s “Who is Ready” series of insights aims to objectively identify names listed on the Tokyo Stock Exchange that are potential additions to the TOPIX Index in future.
  • Anycolor (5032 JP) and Lifedrink (2585 JP) have already confirmed their moves to the Prime Market and are expected to have TOPIX Inclusion Events at the end of July 2023.
  • More recently, Plus Alpha Consulting (4071 JP) announced their move to the Prime Market and are likely to have a TOPIX Inclusion Event at the end of August 2023.

JSR (4185 JP) Takeover – Why So Wide? FUD and Flows

By Travis Lundy

  • In the last week of June, Japanese government-affiliated Japan Investment Corp (“JIC”) announced it would take over JSR Corp (4185 JP). A “surprise” but perhaps not totally. 
  • It traded tight, then it traded back out. Then worse. Then worse again. There were good reasons for this. There were perhaps less good reasons too. 
  • FUD and Flows mean that it is likely to continue to trade wide for the near future.

Kelun-Biotech (科伦博泰) IPO Trading: Lukewarm Demand but Peers Have Done Well Recently

By Ke Yan, CFA, FRM

  • Kelun-Biotech raised HKD 1,259m (USD 161m) from its global offering and will list on the Hong Kong Stock Exchange on Tuesday, July 10th.
  • In our previous note, we looked at the company’s business lines of ADC products. We were of the view that the IPO is fairly priced, at best.
  • In this note, we provide an update for the IPO before trading debut.

S&P/​​​​​​​​ASX Index Rebalance Preview: Potential Changes in September

By Brian Freitas

  • We forecast 22 changes across the ASX50 Index, ASX100 Index, S&P/ASX 200 (AS51 INDEX) and ASX300 Index at the September rebalance.
  • Some of the changes are high probability while others are close to cutoffs. The impact of passive trading will be pretty large on a lot of stocks.
  • Short interest on the potential deletes indicates some pre-positioning but there should still be a fair bit more to do.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars